Sanders Morris Harris LLC Purchases 13,544 Shares of Astera Labs, Inc. $ALAB

Sanders Morris Harris LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 13,544 shares of the company’s stock, valued at approximately $4,821,000.

A number of other institutional investors also recently added to or reduced their stakes in ALAB. BlackRock Inc. bought a new stake in Astera Labs during the second quarter valued at about $6,609,581,000. ABS Investment Management LLC purchased a new position in Astera Labs in the second quarter worth $1,980,382,000. Van ECK Associates Corp grew its holdings in Astera Labs by 20.0% in the second quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock worth $1,080,980,000 after purchasing an additional 373,545 shares during the last quarter. Bank of America Corp DE acquired a new position in shares of Astera Labs during the second quarter worth $1,061,791,000. Finally, Atreides Management LP acquired a new position in shares of Astera Labs during the second quarter worth $587,736,000. Institutional investors own 60.47% of the company’s stock.

Insider Activity

In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction that occurred on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director owned 253,863 shares in the company, valued at approximately $71,114,642.19. This represents a 41.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the transaction, the general counsel directly owned 96,542 shares of the company’s stock, valued at $32,872,551. This represents a 6.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 408,558 shares of company stock valued at $127,306,034. 10.40% of the stock is owned by insiders.

Astera Labs Trading Down 7.7%

Shares of NASDAQ ALAB traded down $25.13 during midday trading on Wednesday, reaching $300.28. The company had a trading volume of 4,579,009 shares, compared to its average volume of 5,172,227. The business’s 50-day simple moving average is $316.78 and its 200 day simple moving average is $294.44. The stock has a market cap of $52.10 billion, a P/E ratio of 148.65 and a beta of 3.68. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to analyst estimates of $360.85 million. During the same period in the previous year, the company earned $0.44 earnings per share. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Analysts predict that Astera Labs, Inc. will post 2.70 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on ALAB shares. Roth Capital reiterated a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. Stifel Nicolaus boosted their target price on Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research note on Wednesday, June 24th. Royal Bank Of Canada upped their target price on Astera Labs from $425.00 to $500.00 and gave the company an “outperform” rating in a research report on Wednesday, August 5th. Morgan Stanley upped their target price on Astera Labs to $335.00 and gave the company an “overweight” rating in a research report on Monday, August 3rd. Finally, UBS Group reiterated a “neutral” rating and issued a $425.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Eleven analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, Astera Labs presently has an average rating of “Moderate Buy” and an average target price of $348.33.

Astera Labs Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.